The Janssen-Achillion Deal Proves My Short Thesis

Summary Janssen signed a deal with ACHN for their Hep C assets. The deal, with many exit hatches, is a disappointment from expectations of takeover. The stock is down as a result of the news. Janssen signed a deal with Achillion (NASDAQ:ACHN) under which Janssen can use one or more [...]